Financial Year |
March 31 2023 |
Monetary Funds |
1,861,816,937.10 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
841,021.00 |
Accounts Receivable |
890,769,599.92 |
Advances to Suppliers |
34,034,186.01 |
Other Receivables |
32,090,853.78 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
112,980,574.33 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
488,632.19 |
Other Current Assets |
118,875,839.31 |
Total Current Assets |
4,001,623,396.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
13,684,228,739.90 |
Investment Properties |
892,406,912.02 |
Fixed Assetes |
2,057,043,094.83 |
Under-construction Projects |
333,758,722.10 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
3,710,672,163.40 |
R&D expenses |
-- |
Goodwill |
4,036,887.63 |
Long-Term Deferred and Prepaid Expenses |
69,577,835.72 |
Deferred Income Tax Assets |
96,811,631.92 |
Other Non-Current Assets |
892,990,523.48 |
Sub-Total of Non-Current Assets |
21,907,006,932.03 |
Total Assets |
25,908,630,328.11 |
Short-Term Loans |
1,293,202,774.55 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
1,231,487,226.75 |
Accounts Received In Advance |
4,217,349.07 |
Employee Compensation Payable |
178,227,129.20 |
Taxes Payable |
29,349,280.26 |
Interest Payable |
-- |
Dividend Payable |
72,279,596.08 |
Other payables |
583,603,343.20 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,164,250,041.81 |
Other Current Liabilities |
598,610,670.46 |
Sub-Total of Current Liabilities |
6,810,883,201.82 |
Long-term Loans |
2,481,821,866.78 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
62,721,941.28 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
4,635,403.80 |
Other Non-Current Liabilities |
110,751,897.07 |
Sub-Total of Non-Current Liabilities |
2,840,276,845.10 |
Total Liabilities |
9,651,160,046.92 |
Paid-In Capital(Or Share Stock) |
1,475,111,351.00 |
Capital Surplus |
1,827,124,337.24 |
Surplus Reserve |
773,395,307.19 |
LESS:Treasury Stock |
53,243,345.97 |
Undistributed Profits |
11,175,372,224.23 |
Minority Stockholder's Interest |
285,948,300.22 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,971,521,980.97 |
Owner's Equity(Stockholder's Equity) |
16,257,470,281.19 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
25,908,630,328.11 |